amfAR, The Foundation for AIDS Research, is one of the world’s leading nonprofit organizations dedicated to the support of AIDS research, HIV prevention, treatment education, and advocacy. Since 1985, amfAR has invested nearly $617 million in its programs and has awarded more than 3,500 grants to research teams worldwide.
amfAR’s top research priority is the pursuit of a cure for HIV/AIDS. From 2015 to 2020, we invested close to $53 million in 109 cure-focused research projects in 15 countries. Grants and fellowships support teams of scientists pursuing innovative strategies including cell and gene therapy, shock and kill, and post-treatment control. Many of these are supported through the amfAR Research Consortium on HIV Eradication, or ARCHE, launched in 2010 to accelerate the pace of cure research. Additionally, amfAR fellowships allow talented young researchers to conduct original investigations under the guidance of experienced scientists, helping to ensure the long-term vitality of AIDS research.
Informed by thorough research and analysis, amfAR is a highly respected advocate of rational and compassionate HIV/AIDS-related public policy. The Foundation is engaged in efforts to secure necessary increases in funding for HIV/AIDS research and global HIV/AIDS programs, expand access to treatment and care for marginalized populations, advocate harm reduction policies aimed at reducing the spread of HIV and hepatitis C (HCV) among people who inject drugs, and protect the civil rights of all people affected by or vulnerable to HIV/AIDS.
Established in 2001, amfAR’s TREAT Asia program (Therapeutics Research, Education, and AIDS Training in Asia) is a collaborative network of clinics, hospitals, research institutions, and civil society that is working to ensure the safe and effective delivery of HIV treatments to adults and children across the Asia-Pacific through research, education and advocacy. The network currently encompasses 20 pediatric and 21 adult sites throughout the region.
This selection of major accomplishments shows the depth and breadth – and impact – of amfAR’s work.